Cardiocast

DOACs found safer than warfarin in the real world


 

The safety of direct oral anticoagulants is affirmed in a real-world study; a wearable ECG boosts atrial fibrillation detection by a factor of 8; new pediatric guidelines catch more hypertension cases in children; and nontraditional cardiovascular risk factors are not ready for prime time, says a federal task force. Listen to MDedge Cardiocast for all the details on the week’s top news, and subscribe on iTunes.

Recommended Reading

Impaired kidney function no problem for dabigatran reversal
MDedge Internal Medicine
Does warfarin cause acute kidney injury?
MDedge Internal Medicine
First reversal agent for apixaban and rivaroxaban gets fast-track approval
MDedge Internal Medicine
Design limitations may have compromised DVT intervention trial
MDedge Internal Medicine
DOAC’s edge over warfarin fades with low adherence
MDedge Internal Medicine
Low vitamin D linked with DVT in lupus patients
MDedge Internal Medicine
Midlife retinopathy predicts ischemic stroke
MDedge Internal Medicine
Canakinumab cut gout attacks in CANTOS
MDedge Internal Medicine
DOJ lawsuit reins in inappropriate ICD use
MDedge Internal Medicine
DOACs’ safety affirmed in real-world setting
MDedge Internal Medicine